Clinical Report: Classification Approaches for Pilonidal Sinus Disease
Overview
Pilonidal sinus disease (PSD) affects predominantly young males and often requires surgical intervention due to its chronic nature and high recurrence rates. This systematic review identified nine classification systems for PSD, highlighting the lack of a universally adopted system to guide treatment and the need for validated, reliable classifications to improve prognostic accuracy and therapeutic decisions.
Background
PSD is a common condition characterized by a spectrum ranging from simple midline pits to complex fistulous tracts. Surgery remains the mainstay of treatment, but recurrence rates can be as high as 60.4% within 24 months postoperatively. Despite multiple surgical techniques, early wound complications such as infection and dehiscence are frequent. Classification systems for PSD are important for prognosis and treatment stratification but are currently underutilized and lack standardization and validation.
Data Highlights
A total of 733 records were screened, with 512 assessed for eligibility. After full-text review, nine studies proposing classification systems for PSD were included. Eight novel classification systems were identified, but none demonstrated comprehensive validation or widespread clinical adoption. Recurrence rates post-surgery can reach 60.4% at 24 months, underscoring the need for improved prognostic tools.
Key Findings
PSD affects approximately 26 per 100,000 individuals, predominantly young employed males.
There is no universally accepted classification system for PSD to guide treatment decisions.
Existing classification systems lack comprehensive validation regarding reliability, validity, and prognostic utility.
Surgical treatment options vary widely, with high recurrence and complication rates.
Classification systems should assess internal consistency, reliability, validity, responsiveness, and interpretability as per COSMIN guidelines.
Current clinical practice relies heavily on clinician experience rather than standardized classification systems.
Clinical Implications
Clinicians should be aware of the heterogeneity in PSD presentation and the limitations of current classification systems. Adoption of a validated, reliable classification system could facilitate stratified treatment approaches, potentially reducing recurrence and complications. Until such systems are established, treatment decisions should consider individual patient presentation and surgeon expertise.
Conclusion
This review highlights the need for an accessible, validated classification system for PSD to improve prognostic accuracy and guide treatment selection. Future research should focus on developing and validating such systems to enhance clinical outcomes.
